Clinical Trials
Bharat Biotech Ends Clinical Trial Of Nasal COVID-19 Vaccine
The clinical phase III trials of the COVID-19 nasal vaccination have been finished, according to the Chairman and Managing Director of Bharat Biotech, Dr. Krishna...
Clinical Trials
Phesi global analysis of 2.5 million patients finds participants...
New analysis from Phesi Inc., a data-driven provider of AI-powered clinical development analytics products and solutions, has found that since 2014 the number of women...
Clinical Trials
Calyx Selected by ProTrials as Partner for Improving Clinical...
Calyx, the eClinical and Regulatory solutions and services provider relied on for solving complex data challenges in clinical research, announced it has been named an...
Clinical Trials
Curebase and Blue Note Therapeutics Collaborate on Home-based Clinical...
Curebase, a company committed to democratizing access to clinical studies, and Blue Note Therapeutics, a prescription digital therapeutics (PDT) company dedicated to easing the burden...
Clinical Trials
IQVIA selected to accelerate clinical development of VYVGART by...
IQVIA announced an agreement today with argenx SE. The multi-year contract covers a unique collaboration for the development of new indications for VYVGARTâ„¢ (efgartigimod alfa...
Clinical Trials
Biohaven Licenses Taldefgrobep Alfa, a Phase 3-Ready Anti-Myostatin Adnectin...
Biohaven Pharmaceutical Holding Company Ltd. announced that it entered into a worldwide license agreement with Bristol Myers Squibb for the development and commercialization rights to...
Clinical Trials
Tesis Biosciences Acquires Genome Explorations to Accelerate Clinical Research...
Tesis Biosciences, the leader in targeted genetic sequencing, has acquired Genome Explorations, a premier research institution providing global genomic profiling and molecular diagnostics services.
The acquisition,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.